Brand Marketer, Retina Products
Harrow
Summary
Owns the retina and in-office brands like biosimilars BYOOVIZ® and OPUVIZ™, plus IOPIDINE®, and adjacent/glaucoma products. Owns biosimilar interchangeability education and payer and HCP trust-building content.
Job description
Position Summary
Owns the retina and in-office brands like biosimilars BYOOVIZ® and OPUVIZ™, plus IOPIDINE®, and adjacent/glaucoma products. Owns biosimilar interchangeability education and payer and HCP trust-building content.
Core Responsibilities
- Build and execute tactical plans for retina and in-office procedure brands.
- Develop biosimilar education for retina specialists, practice staff, and payers, in collaboration with Medical Affairs and Market Access.
- Run merchandising and conversion on the e-commerce platform for adjacent and glaucoma products.
- Develop materials with agencies through PRC approval; support execution of retina congresses (e.g., ASRS).
- Track brand and campaign KPIs; manage budgets, SOWs, and POs.
- Coordinate with the clinical team on new retina product trials and gather feedback.
- Own the BYOOVIZ® and OPUVIZ™ brand plans: positioning, biosimilar adoption campaigns, and forecasts.
- Serve as the subject-matter expert and brand ambassador for the retina brands they own, internally and externally.
- Execute omnichannel campaigns for assigned brands across personal and non-personal channels, and track channel performance.
- Execute account-based marketing (ABM) tactics for target retina groups and in-office procedure accounts with the field and Strategic Accounts.
- Run full-funnel campaigns for assigned brands and report on performance at each stage of the funnel.
Qualifications & Requirements
- Bachelor’s degree; 3–6 years in pharma or biotech marketing, including 2+ in brand or product marketing.
- Has taken materials through PRC/MLR review; familiarity with Veeva PromoMats or similar systems and workflows.
- Able to explain technical clinical and reimbursement topics simply.
- Experience marketing to the retina subspecialty.
- Hands-on experience executing full-funnel marketing campaigns and account-based marketing (ABM) tactics.
- Proficiency with AI platforms such as ChatGPT and Claude, and with Slack.
Preferred Qualifications
- Retina, ophthalmology, or biosimilar experience.
- Buy-and-bill product experience.
- Proficiency with Salesforce, Pardot/HubSpot/etc., Power BI, and Google Analytics; Adobe Suite a plus.
Position Type
Remote (U.S.)
Travel
Approximately 20%
Requirements
- Bachelor’s degree
- 3–6 years in pharma or biotech marketing
- 2+ years in brand or product marketing
- Has taken materials through PRC/MLR review
- Familiarity with Veeva PromoMats or similar systems and workflows
- Able to explain technical clinical and reimbursement topics simply
- Experience marketing to the retina subspecialty
- Hands-on experience executing full-funnel marketing campaigns
- Hands-on experience with account-based marketing (ABM) tactics
- Proficiency with AI platforms such as ChatGPT and Claude
- Proficiency with Slack
Benefits
- Remote (U.S.)
- Approximately 20% travel
- Bonus
Company overview
Harrow Health, Inc. (NASDAQ: HROW) is a publicly traded pharmaceutical company headquartered in Nashville, Tennessee, specializing in ophthalmic healthcare solutions. Founded in 2012 and formerly known as Imprimis Pharmaceuticals, the company has established itself as a growing leader in the ophthalmic pharmaceutical market. Harrow operates through multiple subsidiaries including ImprimisRx, its compounding pharmacy business that produces cGMP ophthalmic eye drops and sterile compounded products. The company's core mission focuses on providing affordable and accessible medications while maintaining an unyielding dedication to innovation. Harrow gained significant attention for developing low-cost alternatives to expensive medications, most notably creating a $1 per pill alternative to Daraprim during the Martin Shkreli controversy. The company's business model emphasizes developing inexpensive alternatives to off-patent medicines where single manufacturers charge excessive prices. With a portfolio that includes branded, generic, and compounded ophthalmic medications, Harrow serves healthcare providers and patients across the United States through its FDA-registered outsourcing facilities and nationwide distribution network.